Big pharmaceutical companies argue that knock off GLP-1 drugs are misleading consumers and violating trade laws.

A consumer safety group says the FDA has sent more than 50 warning letters to telehealth companies over claims about ...

SCHD is no longer an attractive long-term allocation, given recent reconstitution and macro dynamics favoring growth assets. Read more on SCHD ETF here.

Building Dreams ...

Joe Maginot discusses AI-driven U.S. stock gains, rising valuation risks and why overlooked quality growth companies may ...

As much of the Eastern U.S. experiences potentially record-breaking daytime temperatures, the nights are also staying ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US regulator ...

Editor's Note: APYs listed in this article are up-to-date as of the time of publication. They may fluctuate (up or down) as the Fed rate changes. Select will update as changes are made public. Some ...

OHIO OPEN/CONTRIBUTED Tyler Goecke, former Carroll High and Wright State golfer, shot an 8-under par 64 Monday, June 29, 2026 ...

Trump's net income in his first year back in the White House topped $2 billion from myriad business dealings, including South ...